Young Adult Infusion Space Experience Satisfaction Survey

Sponsor
UNC Lineberger Comprehensive Cancer Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05720546
Collaborator
(none)
100
30.9

Study Details

Study Description

Brief Summary

The purpose of this study is to compare the satisfaction of Adolescent and Young Adults (AYA) receiving treatment in two different infusion spaces at the North Carolina Basnight Cancer Hospital (NCBCH). A survey and semi-structured interviews will be administered to participants to compare the experience with the built environment, with mental health staff, and between outpatient infusion spaces at NCBCH.

Condition or Disease Intervention/Treatment Phase
  • Other: Baseline Survey
  • Other: Semi-structured interviews
  • Other: Follow-up Survey

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Young Adult Infusion Space Survey: Comparing Experiences of Adolescents and Young Adults in Infusion Spaces at North Carolina Basnight Cancer Hospital
Anticipated Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
Aug 31, 2025
Anticipated Study Completion Date :
Aug 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Outpatient treatment center

Subjects received an infusion in an outpatient infusion center.

Other: Baseline Survey
A survey that measures participant satisfaction will be offered to participants during infusion at baseline.

Other: Semi-structured interviews
Semi-structured interviews will be conducted in the same infusion spaces.

Other: Follow-up Survey
A survey that measures participant satisfaction will be offered to participants during following infusion.

Inpatient Infusion Center

Subjects received an infusion in an inpatient infusion center.

Other: Baseline Survey
A survey that measures participant satisfaction will be offered to participants during infusion at baseline.

Other: Semi-structured interviews
Semi-structured interviews will be conducted in the same infusion spaces.

Other: Follow-up Survey
A survey that measures participant satisfaction will be offered to participants during following infusion.

Outcome Measures

Primary Outcome Measures

  1. General satisfaction [Baseline (up to 1 month)]

    General satisfaction will be measured with participants' responses to satisfaction surveys that will be administered in specific infusion spaces. Responses are rated on a Likert scale from 0 to 4. Scores will be summarized using frequency tables and percentages.

Secondary Outcome Measures

  1. Satisfaction with the built environment [Baseline (up to 1 month)]

    Subject satisfaction with the built environment will be measured with a survey item specific to the built environment administered in specific infusion spaces. The result of satisfaction in different infusion sites will be compared. Responses are rated on a Likert scale from 0 to 2. Scores will be summarized using frequency tables and percentages.

  2. Satisfaction with staff interaction [Baseline (up to 1 month)]

    Subject satisfaction with staff interaction will be measured with a survey item specific to staff interactions administered in specific infusion spaces. The result of satisfaction in different infusion sites will be compared. Responses are rated on a Likert scale from 0 to 4. Scores will be summarized using frequency tables and percentages.

  3. Satisfaction with mental health [Baseline (up to 1 month)]

    Subject satisfaction with mental health will be measured with survey items regarding emotional support and comfort administered in specific infusion spaces. The result of satisfaction in different infusion sites will be compared. Responses are rated on a Likert scale from 0 to 4. Scores will be summarized using frequency tables and percentages.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 39 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  1. Written informed consent obtained to participate in the study and HIPAA authorization for the release of personal health information.

  2. Subjects are willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.

  3. Age 18-39 years old at enrollment.

  4. Receiving treatment for a cancer diagnosis in Adult Infusion Center or the Adolescent and Young Adult Infusion Center

  5. English speaking.

Exclusion Criteria:
  1. Dementia, altered mental status, or any psychiatric condition as determined by the clinical or study team that would prohibit the understanding or rendering of informed consent.

  2. Current incarceration.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • UNC Lineberger Comprehensive Cancer Center

Investigators

  • Principal Investigator: Jacob Stein, UNC Lineberger Comprehensive Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
UNC Lineberger Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT05720546
Other Study ID Numbers:
  • LCCC2228
First Posted:
Feb 9, 2023
Last Update Posted:
Feb 9, 2023
Last Verified:
Jan 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by UNC Lineberger Comprehensive Cancer Center

Study Results

No Results Posted as of Feb 9, 2023